Nov 27, 2025
Philips and Lumus Imaging Partner to Advance Cardiac and Lung Health Across Queensland
Sydney, Australia – [November 27, 2025] –In a major milestone for patient care and medical imaging in Queensland, Philips Australia and Lumus Imaging have partnered to roll out six state-of-the-art Philips CT 5300 scanners across key locations in the Brisbane region. This strategic partnership not only advances the delivery of high-quality cardiac imaging but also aligns with the Australian Government’s recently launched National Lung Cancer Screening Program (NLCSP), reinforcing both companies’ commitment to providing better care for more people.
The Philips CT 5300 systems have been installed at Lumus Imaging sites in Browns Plains, Sandgate, Peninsula Private Hospital in Kippa-Ring, North Lakes, Ipswich and Meadowbrook. The sixth and most recent installation at Lumus Meadowbrook, like the installation in Ipswich, is particularly notable, marking the first site in the Queensland region to implement the Philips CT 5300 with the full cardiac imaging package. This package includes industry-leading technologies such as Precise Cardiac motion correction and enhanced ECG editing, elevating the standard of non-invasive cardiac assessment.
“Advanced imaging is a critical enabler of better patient outcomes,” said Phil Lucus, CEO of Lumus Imaging. “Our partnership with Philips reflects our shared commitment to investing in technologies that not only improve image quality but also reduce patient exposure and streamline workflows for clinicians. With the CT 5300, we’re delivering more accurate, timely diagnoses and ultimately, more lives saved.”
Transforming Cardiac Imaging The Ipswich site’s adoption of the CT 5300 with comprehensive cardiac capabilities has already shown measurable benefits. Over a two-day period, the scanner facilitated 13 cardiac scans, all of which delivered exceptional imaging clarity. The high resolution and precise motion correction of the system greatly enhance coronary artery visualisation, giving clinicians increased confidence in their diagnoses.
The Precise Cardiac algorithm [1] allows for motion correction using a single series of images, which significantly improves visualization of moving coronary arteries and reduces the need for repeat scans, critical in fast-paced clinical settings.
Equally important is the significant reduction in radiation dose when compared to previous Philips CT systems This is a vital advancement for cardiac patients who often require multiple scans. In addition, enhanced ECG editing capabilities offer a streamlined workflow, saving time for radiographers and improving the quality of final images [2].
Supporting the National Lung Cancer Screening Program The rollout of the CT 5300 also comes at a pivotal moment with the official launch of Australia’s NLCSP. The program targets early detection among high-risk populations, where low-dose CT scanning plays a key role in identifying early-stage lung cancers, often before symptoms appear. “Our investment in this technology aligns perfectly with the objectives of the NLCSP,” added Lucus. “We are proud to support this critical public health initiative and to be delivering advanced CT imaging in communities that need it most.”
The Philips CT 5300’s advanced low-dose capabilities and high-resolution imaging make it ideally suited for use in screening programs where high throughput is required [3].Its speed and precision mean that large volumes of patients can be scanned efficiently without compromising diagnostic quality.
Expanding Access to World-Class Imaging Together, Philips and Lumus Imaging are helping to expand access to cutting-edge diagnostic tools across Queensland. From urban centres to regional communities, this partnership aims to close the gap in early detection and care, ensuring that more Australians benefit from the latest medical technology.
“The installation of the CT 5300 systems is just the beginning,” said Chantal Guziak, Interim General Manager, Health Systems, Philips ANZ. “We are excited to continue working closely with Lumus Imaging to support clinicians and improve patient outcomes through smart, scalable innovations in diagnostic imaging.”
With strong clinical results, enhanced patient safety, and alignment with national health priorities, the Philips-Lumus partnership represents a transformative step forward in the delivery of diagnostic care across Queensland.
References [1] https://www.philips.com/c-dam/b2bhc/master/resource-catalog/landing/precise-suite/incisive_cardiac.pdf [2] https://www.philips.com/a-w/about/investor-relations/in-the-know-with-philips-ir/ct-5300-intelligence-reimagined.html [3] https://www.documents.philips.com/assets/20240223/f4561a9fab3b476cb1ddb11f017514f2.pdf
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
